CHARLOTTE, NC (PR NEWSWIRE) APRIL 05, 2018 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the enrollment of over 100 patients from the United States into the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry.

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017

CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to announce an increase in Medicare payment for prostate HIFU ablation in the Ambulatory Surgical Center (ASC) setting. 

Page 1 of 10

HIFU company

Latest News

03 July 2018

Sonablate® HIFU used in study to treat clinically significant nonmetastatic prostate cancer achieves complete pad-free urinary continence in 98% of men.

17 May 2018

SonaCare Medical congratulates Naren Sanghvi on his receipt of The William and Francis Fry Honorary Fellowship for Contributions to Therapeutic Ultrasound